Skip to main content
. Author manuscript; available in PMC: 2010 Oct 1.
Published in final edited form as: Am Heart J. 2009 Oct;158(4 Suppl):S24–S30. doi: 10.1016/j.ahj.2009.07.017

Table 1.

Baseline demographics

N 1758
Age (yrs) 58.8 (51.0, 67.8)
Body mass index () 30.0 (26.0, 35.5)
Male, n (%) 1245 (70.8)
Race – African American, n (%) 588 (34.0)
            White, n (%) 1055 (61.0)
            Other, n (%) 86 (5.0)
Ejection fraction (%) 24.6 (20.1, 30.1)
Ischemic etiology, n (%) 853 (48.5)
Hypertension, n (%) 1030 (59.0)
Diabetes, n (%) 556 (31.6)
Therapies
            ACE inhibitors, n (%) 1313 (74.7)
            ARB, n (%) 413 (23.5)
            Beta blocker, n (%) 1668 (94.9)
            Digoxin, n (%) 781 (44.4)
            Aldosterone antagonist, n (%) 788 (44.8)
            Biventricular pacemaker, n (%) 290 (16.5)
            ICD, n (%) 687 (39.1)
Systolic blood pressure (mmHg) 110.0 (100.0, 126.0)
Heart rate (bpm) 70.5 (63.0, 79.0)

Values expressed as medians and interquartile ranges or number and percent. ACE – angiotensin converting enzyme, ARB – angiotensin II receptor blocker, bpm – beats per minute, ICD – implantable cardioverter defibrillator